PharmEasy set to buy Thyrocare?
In yet another mega development in the pharmacy space, Thyrocare is all set to be acquired by PharmEasy. As per a media report, the buyout will involve Rs 7,000 crore.
By : migrator
Update: 2021-06-17 19:14 GMT
Chennai
As per the report, the online medical entity PharmEasy is in advanced negotiations with Thyrocare. Incidentally, API Holdings, the parent company of PharmEasy, is gearing up for an IPO listing that is aimed at raising over $1 billion this financial year.
A Velumani founded the diagnostics services chain Thyrocare in 1996. In 2011, he set up the Coimbatore-based Nueclear Healthcare. After a 14-year stint at Bhabha Atomic Research Centre he took the entrepreneurial plunge. Velumani has gone on to create the Thyrocare brand, that is pegged to have a market cap of over $500 million.
Visit news.dtnext.in to explore our interactive epaper!
Download the DT Next app for more exciting features!
Click here for iOS
Click here for Android